top of page
Disruptive tech Cohort- USA LP

Disruptive Tech Launching Pad
US Market Entry 

Apply Now

Build a Decision-Ready U.S. Healthcare Commercial Pathway

Validate your U.S. healthcare opportunity, identify critical market-entry risks, and build a practical commercialization roadmap.


A configurable program for international digital health and medtech companies ready to navigate the complexities of the U.S. healthcare market with greater confidence.

Enter the U.S. Healthcare Market with Confidence

The U.S. healthcare market offers significant opportunities for international digital health and medtech innovators. But successful expansion takes more than a strong product.

 

From product claims and reimbursement to buyer validation and institutional adoption, companies must navigate a complex set of interconnected commercial decisions.

 

The Digital Health Launching Pad brings these challenges into one structured, evidence-led program. Through four configurable specialist workstreams, USA Launching Pad helps you identify readiness gaps, validate your commercial pathway, and prioritize the right next steps before making significant U.S. market investments.

 

One program. Four specialist workstreams. A pathway built around your needs.

What Our Launching Pad Offers 

01. Product Claims & Compliance
Assess whether your product claims are supported by credible evidence and appropriate for U.S. commercial positioning. Identify substantiation gaps, review priority marketing language, and establish a clearer path toward compliant communication.


02. Payer & Reimbursement
Understand how your solution could be funded in the U.S. healthcare system. Map potential payers, budget sources, and reimbursement considerations while evaluating the economic evidence needed to support adoption.


03. Market, GTM & Audience Activation

Identify your priority U.S. customers, refine your value proposition, and evaluate your commercial model. Develop targeted positioning, audience-building priorities, and a practical market-entry strategy supported by healthcare-specific insights.


04. Healthcare Adoption & Strategic Access
Understand how healthcare organizations evaluate, purchase, and implement new solutions. Map decision-makers, clinical champions, institutional barriers, and pilot-readiness requirements to prepare for meaningful market engagement.

​

Launching Pad Timeline

Step 01. Qualify & Configure

Define your U.S. commercial objectives, assess your current readiness, and select the specialist workstreams most relevant to your next business decisions.


Step 02. Evidence Intake

Review your product documentation, clinical evidence, commercial assumptions, target customers, pricing, and existing market-entry materials.


Step 03. Workstream Assessment

Healthcare specialists evaluate the selected readiness dimensions, identify evidence gaps, and assess critical commercial dependencies.


Step 04. Integrated Readiness View

Bring findings together into a consolidated U.S. Readiness Scorecard, connecting product claims, funding, positioning, and institutional adoption.

​

Step 05. Roadmap & Decision Gates

Receive prioritized recommendations, clear decision points, and a practical 90/180/365-day roadmap to guide your next stage of U.S. expansion.

​

Program timing is confirmed after configuration based on selected workstreams, evidence readiness, and stakeholder availability.

Program Value

Resolve Before You Scale.

A strong healthcare solution doesn't automatically translate into a viable U.S. business.

​

Your product claims, economics, commercial model, and institutional adoption pathway must work together.

USA Launching Pad helps you identify critical dependencies early, understand what needs further validation, and make informed decisions about where to invest next.

​

With experience supporting more than 100 companies across four continents, our U.S.-European team combines proven commercialization methodology with healthcare-specific expertise.

​

The goal: Greater clarity. Lower market-entry risk. Better-informed investment decisions.

​

“The speed at which we generated leads and pilot projects is a testament to the effectiveness of the USA Launching Pad method.”


— David Eberle, Typewise CEO

Meet the Team

Profile Picture Gert Christen, San Francisco cropped.png

Gert Christen
CEO & Co-Founder, USA Launching Pad

Matt_DiMarsico_Headshot_Website_1536.webp

Matt DiMarsico
Co-Founder,
USA Launching Pad

Launching Pad Configurations

Choose the Right Path for Your U.S. Expansion

Every digital health company faces different challenges when entering the U.S. market.

Rather than requiring a fixed program, the Digital Health Launching Pad allows you to select one, several, or all four specialist workstreams based on your current needs.

​

Focused Workstream

Resolve a critical U.S. market-entry question.

Designed for companies facing one priority challenge, such as product-claims substantiation, payer economics, or institutional adoption readiness.

Receive a focused assessment and actionable recommendations before moving forward with broader market-entry activities.

​

Configured Readiness Review

Connect the decisions that matter most.

Ideal for companies with two or three interconnected commercial-readiness challenges.

Combine selected workstreams to understand dependencies, identify gaps, and establish a more coordinated U.S. commercialization pathway.

​

Integrated Digital Health Launching Pad

Build a comprehensive U.S. readiness roadmap.

For companies requiring assessment across all four specialist workstreams.

Receive an integrated readiness scorecard, consolidated findings, a recommended commercial-pathway hypothesis, and a prioritized 90/180/365-day roadmap.

​

Program investment is determined following intake and configuration, based on selected workstreams and integration requirements.

Are you a match for our Launching Pad?

A Working Digital Health or Medtech Solution

You have a commercially active product outside the U.S. or a sufficiently mature solution ready for U.S. validation.

A Focus on Institutional Healthcare Buyers

You sell, or intend to sell, to healthcare providers, health systems, payers, employers, or other institutional customers.

A Need for U.S. Commercial Validation

You want to understand your buyers, funding pathways, product claims, market positioning, or institutional adoption requirements.

A Commitment to Evidence-Led Expansion

You're ready to identify critical gaps and validate your commercial assumptions before investing heavily in U.S. sales, partnerships, pilots, or hiring.

Apply Now

Frequently asked questions

Ready to Navigate the U.S. Healthcare Market?

Turn market-entry uncertainty into a clearer commercial pathway.

Identify the right opportunities, address critical readiness gaps, and build your next steps around evidence, not assumptions.

bottom of page